A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project

Abstract

Angiotensin II, a vasoconstrictor and the main effector molecule of the renin–angiotensin system, is known to influence inflammation, thrombosis, low-density lipoprotein oxidation and growth factors, all of which contribute to cardiovascular disease. The associations of polymorphisms in the angiotensin-converting enzyme 2 (ACE2) gene with cardiovascular risk have not been fully determined. Single nucleotide polymorphisms (SNPs) in ACE2 were genotyped in participants of the prospective MORGAM study (n = 5092) from five cohorts: ATBC, FINRISK, Northern Sweden, PRIME/Belfast and PRIME/France. Using a case-cohort design, associations were sought between SNPs and haplotypes with cardiovascular events during follow-up (Cox proportional hazards model). The comparison group were a subset of all MORGAM participants who were selected to ensure similar age and sex distributions among the cases and controls. The A allele of the rs2285666 SNP (HR = 0.3, p = 0.04) was significantly associated with the risk of cardiovascular death in female subjects. These findings complement those found in other studies of SNPs in the ACE2 gene in relation to cardiovascular disease risk. As females carry two copies of the ACE2 gene, and given its plausible biological role in cardiovascular disease risk, further studies of ACE2 should be prioritised.

Keywords

Cardiovascular disease case-cohort haplotypes polymorphisms renin–angiotensin system

Get full access to this article

View all access options for this article.

References

Oparil

Haber

. The renin-angiotensin system (second of two parts). N Engl J Med 1974; 291: 446–457.

Oparil

Haber

. The renin-angiotensin system (first of two parts). N Engl J Med 1974; 291: 389–401.

Pratt

. Angiotensin II and the control of cardiovascular structure. J Am Soc Nephrol 1999; 10(Suppl 11): S120–S128.

Schmidt-Ott

Kagiyama

Phillips

. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000; 93: 65–77.

Braun-Menendez

Fasciolo

Leloir

Munoz

. The substance causing renal hypertension. J Physiol 1940; 98: 283–298.

Kranzhofer

Schmidt

Pfeiffer

Hagl

Libby

Kubler

. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1623–1629.

Hayek

Kaplan

Raz

Keidar

Coleman

Aviram

. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Atherosclerosis 2002; 161: 65–74.

Hoshida

Yamashita

Kawahara

Kuzuya

Hori

. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms. Circulation 1999; 99: 434–440.

Dorge

Behrends

Schulz

Jalowy

Heusch

. Attenuation of myocardial stunning by the AT1 receptor antagonist candesartan. Basic Res Cardiol 1999; 94: 208–214.

10.

Yusuf

Sleight

Pogue

Bosch

Davies

Dagenais

. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145–153.

11.

Vidt

. Telmisartan, ramipril, or both in patients at high risk for vascular events. Curr Hypertens Rep 2008; 10: 343–344.

12.

Donoghue

Hsieh

Baronas

. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1–E9.

13.

Tipnis

Hooper

Hyde

Karran

Christie

Turner

. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238–33243.

14.

Vickers

Hales

Kaushik

. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277: 14838–14843.

15.

Santos

Castro

Gava

. Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension 2006; 47: 996–1002.

16.

Jeunemaitre

. Genetics of the human renin angiotensin system. J Mol Med 2008; 86: 637–641.

17.

Frossard

Malloy

Lestringant

Kane

. Haplotypes of the human renin gene associated with essential hypertension and stroke. J Hum Hypertens 2001; 15: 49–55.

18.

Yang

Huang

. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clin Sci (Lond) 2006; 111: 333–340.

19.

Vangjeli

Clarke

Quinn

. Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure. Circ Cardiovasc Genet 2010; 3: 53–59.

20.

Zhong

Yan

Liu

. Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med 2006; 147: 91–95.

21.

Palmer

Jarvis

Pilbrow

. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J 2008; 156: 752–758.

22.

Evans

Salomaa

Kulathinal

. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol 2005; 34: 21–27.

23.

Kulathinal

S NM

Kuulasmaa

, contributors from Participating Centres, for the MORGAM Project. Description of MORGAM Cohorts, 2005.

24.

Kulathinal

Karvanen

Saarela

Kuulasmaa

. Case-cohort design in practice – experiences from the MORGAM Project. Epidemiol Perspect Innov 2007; 4: 15.

25.

Miller

Dykes

Polesky

. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

26.

Moore

Dicker

O’Brien

. Renin gene polymorphisms and haplotypes, blood pressure, and responses to renin-angiotensin system inhibition. Hypertension 2007; 50: 340–347.

27.

Purcell

Neale

Todd-Brown

. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

28.

Tobin

Sheehan

Scurrah

Burton

. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24: 2911–2935.

29.

Lieb

Graf

Gotz

. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J Mol Med 2006; 84: 88–96.

30.

Wang

Zou

. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chin Med J (Engl). 2008; 121: 27–31.

31.

Yan

. [Relationship of angiotensin-converting enzyme 2 gene polymorphisms and vulnerability to coronary heart disease in patients with type 2 diabetes mellitus]. Nan Fang Yi Ke Da Xue Xue Bao. 2008; 28: 1365–1368.

32.

Wang

. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res 2006; 34: 272–283.

33.

Komukai

Mochizuki

Yoshimura

. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol 2010; 24: 687–698.

34.

Benjafield

Wang

Morris

. No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens 2004; 17: 624–628.

35.

Huang

Yang

Wang

Zhao

Chen

. Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J Hum Hypertens 2006; 20: 968–971.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB